We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Asian Journal of Current Research in Clinical Cancer

2025 Volume 5 Issue 1

The Alternative Splicing of CLSTN1 Driven by ESRP1 Suppresses Gastric Cancer Metastasis


,
  1. Department of Clinical Oncology, School of Medicine, Trinity College Dublin, Dublin, Ireland.
Abstract

The spread of tumors significantly worsens outcomes for individuals with gastric cancer. RNA-binding proteins (RBPs) play key roles in cancer spread, although their specific contributions to gastric cancer remain underexplored. In this work, we identified ESRP1, an epithelial-specific RBP, as a critical modulator of metastatic behavior in gastric cancer cells. Levels of ESRP1 show an inverse association with both distant and lymph node metastases in affected patients. Experiments confirmed that ESRP1 suppresses cell migration and invasion in gastric cancer models both in laboratory settings and animal studies. At the molecular level, ESRP1 facilitates alternative splicing of exon 11 in CLSTN1 pre-mRNA. The resulting shorter isoform of CLSTN1 strengthens the interaction between E-cadherin and β-catenin, while enhancing ubiquitination and subsequent degradation of β-catenin protein, ultimately restraining migratory and invasive properties of gastric cancer cells. This investigation underscores ESRP1's suppressive influence on gastric cancer spread and uncovers additional mechanistic insights. Findings suggest that ESRP1 and CLSTN1 could serve as promising targets for interventions against metastatic gastric cancer.


How to cite this article
Vancouver
Fernandez E, Moore MQ. The Alternative Splicing of CLSTN1 Driven by ESRP1 Suppresses Gastric Cancer Metastasis. Asian J Curr Res Clin Cancer. 2025;5(1):177-95. https://doi.org/10.51847/cZOZ2TW0T4
APA
Fernandez, E., & Moore, M. Q. (2025). The Alternative Splicing of CLSTN1 Driven by ESRP1 Suppresses Gastric Cancer Metastasis. Asian Journal of Current Research in Clinical Cancer, 5(1), 177-195. https://doi.org/10.51847/cZOZ2TW0T4
Articles
Long-Term Survival Outcomes of Colorectal Cancer Survivors: An In-Depth Exploration
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Zhaobei Cai
Theoretical Model of Thiophene and Its Derivatives Interaction with BRCA-1
Asian Journal of Current Research in Clinical Cancer
Vol 4 Issue 2, 2024 | Lauro FigueroaValverde
A Three-Decade Overview of Female-Specific Cancers in Malaysia: A Thorough Examination
Asian Journal of Current Research in Clinical Cancer
Vol 4 Issue 2, 2024 | Tahir Mehmood Khan
An Overview of Targeted Therapy Applications in Cancer Treatment
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Yeuan Ting Lee
Exploring Advanced Diagnostic Techniques for Salivary Gland Disorders: A Narrative Overview
Asian Journal of Current Research in Clinical Cancer
Vol 4 Issue 1, 2024 | Chuan Xiang Li
Exploring the Radiosensitizing Effects of Tolmetin in Radiotherapy for Human Clonal Cancer Cells
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Deep Kwatra
Comparative Analysis of BRCA1 and BRCA2 Mutation–Associated Breast Cancer in a Japanese Cohort
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 2, 2025 | Ravi Kumar
Somatic Alterations in TP53 and KRAS and Their Functional Impact in Epithelial Ovarian Cancer
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 2, 2025 | Lucas Meyer

About GalaxyPub

Find out more

Established in 2019, Galaxy Publication stands as a global academic publishing house focused on advancing scholarly work across medicine, nursing, and health sciences. Through its network of peer-reviewed journals, the organization brings together original research and academic contributions from scholars around the world, creating a shared space for knowledge exchange and intellectual collaboration.